Pre-Clinical: B

Grade B: One peer-reviewed publication reporting benefits in a well-designed study (*)

Ivermectin 

Ivermectin has plausible mechanisms for modulating ALS pathways, particularly by decreasing neuroinflammation via inhibiting NF-κB and STAT3 signaling pathways and also by modulating excitotoxicity via GABA_A and P2X4 receptor interactions.…

Read more Ivermectin 

ISRIB

ISR over-activation may play an important role in ALS pathogenesis, as supported by data from pre-clinical models and PALS. Several different ISR inhibitors have been tried in ALS models or…

Read more ISRIB

Insulin

Insulin treatment for ALS is an intriguing area for future research. However, the risks of insulin administration are significant and potentially lethal. Currently, there is no clinical evidence to support…

Read more Insulin

Fecal Transplants

There is rapidly expanding evidence implicating alterations in the fecal microbiome in wide-ranging human diseases, including potential contributions via a gut-brain signaling axis in neurodegenerative and neuroimmunologic disorders. Proposed mechanisms…

Read more Fecal Transplants

Cannabis

Cannabis has biological properties including immunomodulation and effects on excitototoxicity that suggest it could be useful in ALS. Evidence from small, non-randomized, unblinded animal studies suggest that it could potentially…

Read more Cannabis